Filing Details
- Accession Number:
- 0001181431-10-051078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-15 17:38:47
- Reporting Period:
- 2010-10-15
- Filing Date:
- 2010-10-15
- Accepted Time:
- 2010-10-15 17:38:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
897075 | Repros Therapeutics Inc. | RPRX | Biological Products, (No Disgnostic Substances) (2836) | 760233274 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208491 | Joseph Podolski | 2408 Timberloch Place Suite B-7 The Woodlands TX 77380 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-15 | 13,000 | $1.37 | 50,945 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares have been adjusted to reflect the 1-for-4 reverse stock split of the Issuer's common stock, which was effective October 14, 2010.
- 75 shares are owned by certain family members of the reporting person.